127.04
Irhythm Holdings Inc stock is traded at $127.04, with a volume of 90,026.
It is down -0.66% in the last 24 hours and down -13.38% over the past month.
iRhythm Holdings Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.
See More
Previous Close:
$127.95
Open:
$127.09
24h Volume:
90,026
Relative Volume:
0.15
Market Cap:
$4.11B
Revenue:
$747.14M
Net Income/Loss:
$-44.55M
P/E Ratio:
-90.05
EPS:
-1.4108
Net Cash Flow:
$34.52M
1W Performance:
-9.32%
1M Performance:
-13.38%
6M Performance:
-29.79%
1Y Performance:
+18.04%
Irhythm Holdings Inc Stock (IRTC) Company Profile
Name
Irhythm Holdings Inc
Sector
Industry
Phone
415-632-5700
Address
699 8TH STREET, San Francisco, CA
Compare IRTC vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
IRTC
Irhythm Holdings Inc
|
127.24 | 4.13B | 747.14M | -44.55M | 34.52M | -1.4108 |
|
ABT
Abbott Laboratories
|
111.66 | 196.53B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
375.79 | 146.14B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
93.55 | 122.74B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
71.64 | 107.15B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
84.63 | 49.45B | 6.07B | 1.06B | 1.34B | 1.8063 |
Irhythm Holdings Inc Stock (IRTC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-05-26 | Upgrade | Evercore ISI | In-line → Outperform |
| Sep-23-25 | Initiated | Evercore ISI | In-line |
| Aug-20-25 | Initiated | BofA Securities | Buy |
| May-02-25 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Dec-03-24 | Resumed | Wells Fargo | Equal Weight |
| Oct-04-24 | Initiated | Goldman | Neutral |
| Jun-20-24 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Dec-11-23 | Upgrade | Citigroup | Neutral → Buy |
| Jul-19-23 | Initiated | Robert W. Baird | Outperform |
| Feb-07-23 | Initiated | Wells Fargo | Overweight |
| Nov-07-22 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| Jun-09-22 | Downgrade | Citigroup | Buy → Neutral |
| Apr-06-22 | Initiated | Wolfe Research | Underperform |
| Feb-24-22 | Upgrade | Needham | Hold → Buy |
| Jan-18-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jan-12-22 | Upgrade | BTIG Research | Neutral → Buy |
| Jan-11-22 | Upgrade | Oppenheimer | Perform → Outperform |
| Dec-21-21 | Resumed | Canaccord Genuity | Buy |
| Dec-17-21 | Upgrade | JP Morgan | Neutral → Overweight |
| Dec-15-21 | Upgrade | Citigroup | Neutral → Buy |
| Jun-02-21 | Downgrade | Citigroup | Buy → Neutral |
| Apr-13-21 | Downgrade | BTIG Research | Buy → Neutral |
| Apr-12-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Feb-26-21 | Downgrade | Colliers Securities | Buy → Neutral |
| Jan-29-21 | Reiterated | Needham | Hold |
| Nov-17-20 | Downgrade | Oppenheimer | Outperform → Perform |
| Sep-11-20 | Initiated | Needham | Hold |
| Sep-02-20 | Initiated | Robert W. Baird | Neutral |
| Aug-07-20 | Upgrade | Colliers Securities | Neutral → Buy |
| Aug-05-20 | Upgrade | Oppenheimer | Perform → Outperform |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-06-20 | Initiated | BTIG Research | Buy |
| Jan-10-20 | Initiated | William Blair | Outperform |
| Jan-08-20 | Initiated | SunTrust | Buy |
| Oct-22-19 | Initiated | Oppenheimer | Perform |
| Feb-20-19 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| Sep-13-18 | Reiterated | Canaccord Genuity | Buy |
| Sep-06-18 | Initiated | Chardan Capital Markets | Buy |
| Aug-02-18 | Upgrade | Dougherty & Company | Sell → Neutral |
| Jul-16-18 | Downgrade | Dougherty & Company | Neutral → Sell |
| Dec-01-17 | Initiated | Dougherty & Company | Neutral |
View All
Irhythm Holdings Inc Stock (IRTC) Latest News
iRhythm Holdings (NASDAQ: IRTC) EVP sells 2,830 RSU tax shares - Stock Titan
iRhythm (IRTC) officer sells 4,027 shares to cover RSU taxes - Stock Titan
iRhythm Holdings (IRTC) EVP sells 1,352 shares for RSU tax withholding - Stock Titan
iRhythm (IRTC) officer sells 4,444 shares to cover RSU tax obligations - Stock Titan
iRhythm (IRTC) CBO/CLO sells 4,357 shares to cover RSU taxes - Stock Titan
iRhythm (IRTC) CAO sells 816 shares in tax-withholding stock transactions - Stock Titan
iRhythm Holdings CEO Sells Shares to Cover Tax Obligations - TradingView
iRhythm (IRTC) CFO sells 3,395 shares to cover RSU tax obligations - Stock Titan
iRhythm (NASDAQ: IRTC) CEO sells 13,813 shares to cover RSU taxes - Stock Titan
IRTC Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
iRhythm Holdings, Inc. (IRTC) Reports $5.6M Net Income, 70.9% Gross Margin in Q4 2025 - Bitget
How The iRhythm Holdings (IRTC) Story Is Shifting As Targets Reset And Guidance Holds - Yahoo Finance
Q4 2025 iRhythm Holdings, Inc Earnings Call Transcript - GuruFocus
iRhythm (IRTC) CFO receives 8,361 new RSUs in equity grant - Stock Titan
iRhythm (IRTC) executive granted 10,034 RSUs in new equity award - Stock Titan
iRhythm (IRTC) CEO Quentin Blackford receives 31,842 RSU equity grant - Stock Titan
Executive Chad Patterson granted 10,870 RSUs at iRhythm (IRTC) - Stock Titan
iRhythm (NASDAQ: IRTC) CAO receives 2,508-share RSU grant - Stock Titan
iRhythm (IRTC) EVP awarded 6,689 RSUs in new equity grant - Stock Titan
iRhythm (IRTC) EVP Sean Freeman awarded 7,525 RSUs in new Form 4 - Stock Titan
iRhythm (IRTC) EVP, Chief Risk Officer awarded 5,518 RSUs in Form 4 - Stock Titan
Equity award boosts iRhythm (IRTC) CTO holdings with 6,689 RSUs - Stock Titan
IRhythm Holdings Insider Sold Shares Worth $1,056,809, According to a Recent SEC Filing - marketscreener.com
iRhythm Holdings chief comm & product officer sells $1.2m in shares By Investing.com - Investing.com South Africa
iRhythm Holdings chief comm & product officer sells $1.2m in shares - Investing.com
iRhythm Holdings CFO Wilson sells $702,553 in shares - Investing.com India
iRhythm Holdings CFO Wilson sells $702,553 in shares By Investing.com - Investing.com UK
IRhythm : Statement of Changes in Beneficial Ownership (Form 4) - marketscreener.com
iRhythm Holdings EVP Smith sells $547k in stock By Investing.com - Investing.com South Africa
iRhythm (IRTC) CFO gains RSU shares, then sells 5,188 to cover taxes - Stock Titan
[Form 4] iRhythm Holdings, Inc. Insider Trading Activity - Stock Titan
iRhythm (IRTC) CMO receives 15,060 RSU shares, sells 7,804 to cover taxes - Stock Titan
Irhythm Holdings Insider Sold Shares Worth $649,604, According to a Recent SEC Filing - marketscreener.com
iRhythm (IRTC) risk chief nets RSU award, sells shares for taxes - Stock Titan
Irhythm Holdings Insider Sold Shares Worth $1,214,301, According to a Recent SEC Filing - marketscreener.com
iRhythm (IRTC) CAO nets RSU award, sells shares for tax withholding - Stock Titan
Chad Patterson of iRhythm (NASDAQ: IRTC) gains RSU shares, sells some for taxes - Stock Titan
iRhythm (IRTC) CEO nets performance shares, sells portion to cover taxes - Stock Titan
Insider Sell: Mervin Smith Sells Shares of iRhythm Holdings Inc (IRTC) - GuruFocus
Smith Mervin, iRhythm Holdings EVP, sells $103k in IRTC stock By Investing.com - Investing.com Australia
Smith Mervin, iRhythm Holdings EVP, sells $103k in IRTC stock - Investing.com Australia
iRhythm Holdings CAO Rosenbaum sells $39k in shares By Investing.com - Investing.com Canada
iRhythm Holdings CAO Rosenbaum sells $39k in shares - Investing.com UK
iRhythm Technologies, Inc. (NASDAQ:IRTC) Q4 2025 Earnings Call Transcript - Insider Monkey
iRhythm Technologies, Inc. (NASDAQ:IRTC) Q4 2025 earnings call transcript - MSN
iRhythm Holdings Director Abhijit Y Talwalkar Sells 5,312 Shares - TradingView
Director at iRhythm (NASDAQ: IRTC) sells 5,312 shares under plan - Stock Titan
Here’s Artisan Mid Cap Fund’s Updates on iRhythm (IRTC) - Insider Monkey
iRhythm Holdings, Inc. (IRTC) Stock Analysis: Exploring a 41% Upside Potential in the Healthcare Sector - DirectorsTalk Interviews
iRhythm, agilon health, GoodRx, Fortrea, and Myriad Genetics Stocks Trade Down, What You Need To Know - Finviz
Where iRhythm Holdings Stands With Analysts - Benzinga
Irhythm Holdings Inc Stock (IRTC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):